FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584396564> ?p ?o ?g. }

• W2584396564 endingPage "353" @default.
• W2584396564 startingPage "347" @default.
• W2584396564 abstract "RNA helicase, DDX3 is a multifunctional enzyme and is known to be associated with several diseases like HIV progression, brain and breast cancer. Some of the ring expanded nucleoside compounds such as REN: NZ51, fused di imidazodiazepine ring (RK33), (Z)-3-(5- (3-bromo benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(2- hydroxy phenyl) propanamide compound (FE15) have been documented to inhibit DDX3 helicase activity. However, synthesis of these drugs is limited to few research groups. Prevalence of literature study, we found that doxorubicin form strong hydrogen bond interactions with crystallized form of DDX3 using in-silico molecular docking approach. To evaluate the biological inhibitory action of doxorubicin, we performed the ATPase activity assay and anti-cancer activity using H357 cancer cell lines. Results showed that doxorubicin continually declined the inorganic phosphate (Pi) release and inhibited the ATP hydrolysis by directly interacting with DDX3. Anticancer activity was detected by MTT assay. The half maximal inhibitory concentrations of doxorubicin (IC50) for H357 cancer cell line is 50 μM and also doxorubicin significantly down regulated the expression of DDX3. Taken together, our results demonstrate, that inhibition of DDX3 expression by using doxorubicin can be used as an ideal drug candidate to treat DDX3 associated cancer disorder by interacting with unique amino acid residues (Thr 198) and common amino acid residues (Tyr 200 and Thr 201)." @default.
• W2584396564 created "2017-02-10" @default.
• W2584396564 creator A5000629076 @default.
• W2584396564 creator A5005229191 @default.
• W2584396564 creator A5011976546 @default.
• W2584396564 creator A5057540021 @default.
• W2584396564 creator A5069057849 @default.
• W2584396564 creator A5078620936 @default.
• W2584396564 creator A5089058331 @default.
• W2584396564 creator A5091237392 @default.
• W2584396564 date "2016-10-12" @default.
• W2584396564 modified "2023-10-17" @default.
• W2584396564 title "In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3" @default.
• W2584396564 cites W1495509342 @default.
• W2584396564 cites W1565432690 @default.
• W2584396564 cites W1965984331 @default.
• W2584396564 cites W1978935891 @default.
• W2584396564 cites W1993374643 @default.
• W2584396564 cites W1993922319 @default.
• W2584396564 cites W1996327813 @default.
• W2584396564 cites W2000203440 @default.
• W2584396564 cites W2000962656 @default.
• W2584396564 cites W2001073773 @default.
• W2584396564 cites W2006290700 @default.
• W2584396564 cites W2011383767 @default.
• W2584396564 cites W2019300904 @default.
• W2584396564 cites W2020429039 @default.
• W2584396564 cites W2021795261 @default.
• W2584396564 cites W2030319693 @default.
• W2584396564 cites W2033414065 @default.
• W2584396564 cites W2046174017 @default.
• W2584396564 cites W2051848082 @default.
• W2584396564 cites W2063530191 @default.
• W2584396564 cites W2066430486 @default.
• W2584396564 cites W2068264550 @default.
• W2584396564 cites W2077804275 @default.
• W2584396564 cites W2078188527 @default.
• W2584396564 cites W2084905199 @default.
• W2584396564 cites W2086242575 @default.
• W2584396564 cites W2089040379 @default.
• W2584396564 cites W2091438758 @default.
• W2584396564 cites W2107806932 @default.
• W2584396564 cites W2123883227 @default.
• W2584396564 cites W2143343444 @default.
• W2584396564 cites W2148853951 @default.
• W2584396564 cites W2150540364 @default.
• W2584396564 cites W2154263589 @default.
• W2584396564 cites W2154981466 @default.
• W2584396564 cites W2155908452 @default.
• W2584396564 cites W2156734818 @default.
• W2584396564 cites W2160564081 @default.
• W2584396564 cites W2163195695 @default.
• W2584396564 cites W2179609754 @default.
• W2584396564 cites W2395089256 @default.
• W2584396564 doi "https://doi.org/10.6026/97320630012347" @default.
• W2584396564 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5311078" @default.
• W2584396564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28246464" @default.
• W2584396564 hasPublicationYear "2016" @default.
• W2584396564 type Work @default.
• W2584396564 sameAs 2584396564 @default.
• W2584396564 citedByCount "17" @default.
• W2584396564 countsByYear W25843965642018 @default.
• W2584396564 countsByYear W25843965642019 @default.
• W2584396564 countsByYear W25843965642020 @default.
• W2584396564 countsByYear W25843965642021 @default.
• W2584396564 countsByYear W25843965642022 @default.
• W2584396564 countsByYear W25843965642023 @default.
• W2584396564 crossrefType "journal-article" @default.
• W2584396564 hasAuthorship W2584396564A5000629076 @default.
• W2584396564 hasAuthorship W2584396564A5005229191 @default.
• W2584396564 hasAuthorship W2584396564A5011976546 @default.
• W2584396564 hasAuthorship W2584396564A5057540021 @default.
• W2584396564 hasAuthorship W2584396564A5069057849 @default.
• W2584396564 hasAuthorship W2584396564A5078620936 @default.
• W2584396564 hasAuthorship W2584396564A5089058331 @default.
• W2584396564 hasAuthorship W2584396564A5091237392 @default.
• W2584396564 hasBestOaLocation W25843965641 @default.
• W2584396564 hasConcept C104317684 @default.
• W2584396564 hasConcept C121608353 @default.
• W2584396564 hasConcept C161223559 @default.
• W2584396564 hasConcept C181199279 @default.
• W2584396564 hasConcept C185592680 @default.
• W2584396564 hasConcept C202751555 @default.
• W2584396564 hasConcept C2776694085 @default.
• W2584396564 hasConcept C2777752497 @default.
• W2584396564 hasConcept C2780783641 @default.
• W2584396564 hasConcept C2781303535 @default.
• W2584396564 hasConcept C502942594 @default.
• W2584396564 hasConcept C54355233 @default.
• W2584396564 hasConcept C55493867 @default.
• W2584396564 hasConcept C67705224 @default.
• W2584396564 hasConcept C68592252 @default.
• W2584396564 hasConcept C86803240 @default.
• W2584396564 hasConcept C96232424 @default.
• W2584396564 hasConceptScore W2584396564C104317684 @default.
• W2584396564 hasConceptScore W2584396564C121608353 @default.
• W2584396564 hasConceptScore W2584396564C161223559 @default.
• W2584396564 hasConceptScore W2584396564C181199279 @default.

• next